Navigation Links
Aflac Incorporated Announces Fourth Quarter Results
Date:1/30/2008

COLUMBUS, Ga., Jan. 30 /PRNewswire-FirstCall/ -- Aflac Incorporated (NYSE: AFL) today reported its fourth quarter results.

Total revenues benefited from the strengthening of the yen to the dollar in the fourth quarter, rising 9.0% to $4.0 billion, compared with $3.7 billion in the fourth quarter of 2006. Net earnings were $382 million, or $.78 per diluted share, compared with $332 million, or $.67 per share, a year ago. Net earnings included realized investment losses of $1 million, or nil per diluted share, compared with a gain of $3 million, or $.01 per diluted share in the fourth quarter of 2006. The change in fair value of the interest rate component of the cross-currency swaps related to the company's senior notes, as required by SFAS 133, increased net earnings by $1 million, or nil per diluted share, in the fourth quarter of 2007. The impact from SFAS 133 in the fourth quarter of 2006 was immaterial to net earnings and net earnings per diluted share.

We believe that an analysis of operating earnings, a non-GAAP financial measure, is vitally important to an understanding of Aflac's underlying profitability drivers. We define operating earnings as the profits we derive from our operations before realized investment gains and losses, the impact from SFAS 133, and nonrecurring items. Management uses operating earnings to evaluate the financial performance of Aflac's insurance operations because realized gains and losses, the impact from SFAS 133, and nonrecurring items tend to be driven by general economic conditions and events, and therefore may obscure the underlying fundamentals and trends in Aflac's insurance operations.

Furthermore, because a significant portion of our business is in Japan, where our functional
'/>"/>

SOURCE Aflac Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1%
2. Aflac to Sponsor Iron Girl
3. Aflac Incorporated to Present at the Goldman Sachs Financial Services CEO Conference 2007
4. Aflac Japan To Offer Cancer Insurance Product Through Japan Post
5. Aflac Honors Hispanic Entrepreneurs Making a Difference in Texas
6. Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend
7. Aflac Incorporated to Release Third Quarter Results On October 23, 2007
8. Aflac Announces Resignation of U.S. Marketing Officer
9. Susan G. Komen for the Cures Circle of Promise and The Links, Incorporated Unite to Rewrite the Story on African Americans and Breast Cancer
10. Accuray Incorporated to Report Second Quarter Fiscal Year 2008 Financial Results
11. ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...The vaccine that protects children against measles...ccine joins a growing list of scarce drugs, with s...gmakers// and pharmaceutical companies choosing to...ion is so bad that 8 of the 11 recommended childho...
...Obesity is no longer an exclusively Western proble...ious health threat to people in developing nations...d infectious diseases// have been the biggest thre...untries. Now, rapid shifts in urbanisation, techno...
...According to researchers a new has been found way ...ee into cartilage that could be used to repair kne...tial of tissue engineering where replacement// or ...s. Central to this is the ability of stem cells pr...
...Researchers have validated that unmarried men tend...elieve that a marital relationship may benefit men...// Researchers in Stockholm found they also found ...d stroke were higher in unmarried men than in marr...
Other Medicine News:
(Date:9/6/2008)... Demonstrate Safety and Efficacy of First-in-Class...r the Treatment of Acute Migraine, LONDON, Sept. ...n,innovative biotechnology company focusing on the...nced Phase II results of its lead compound COL-144...strated that COL-144 was,safe and effective in rel...
(Date:9/5/2008)...H SAN FRANCISCO, Calif., Sept. 5 /PRNewswire-First...cused on small molecule LFA-1 inhibitors,to treat ..., Inc. (Nasdaq:,SNSS) today announced SARcode,s in...lecule LFA-1 product candidate for T-cell mediated...into a license agreement providing,SARcode with an...
(Date:9/4/2008)...MATEO, Calif., Sept. 4 /- B...ced that the pivotal clinical study of,Polidocanol...r, Chemische,Fabrik KREUSSLER & Co. GmbH (Kreussle...d has been submitted to FDA as part of a New Drug ...al study, named the EASI (Efficacy and safety of,A...
(Date:9/4/2008)... Study Seeks to Enroll 750 Women at More Than 100 ...ewswire/ -- QuatRx Pharmaceuticals, a,privately-he...t and,commercialization of compounds to treat endo...ay announced that it has initiated a second,Phase ...), the company,s,estrogen-free oral therapy in dev...
Breaking Medicine Technology:Phase II Results of COL-144 Presented at European Headache and Migraine Trust International Congress 2008 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Can certain metals repel sharks from fishing gear 3F 2995 1Can certain metals repel sharks from fishing gear 3F 2995 2Can certain metals repel sharks from fishing gear 3F 2995 3The SCOOTER Store and Their Employees Contribute 2443 000 in MS150 Bike Ride to Help Texans With Multiple Sclerosis 17453 1The SCOOTER Store and Their Employees Contribute 2443 000 in MS150 Bike Ride to Help Texans With Multiple Sclerosis 17453 2Orchard Supply Hardware Partners With Canary Foundation 17448 1Orchard Supply Hardware Partners With Canary Foundation 17448 2Orchard Supply Hardware Partners With Canary Foundation 17448 3febit to Introduce Geniom RT Analyzer 28R 29 to U S Market at RNAi World Congress 4775 1febit to Introduce Geniom RT Analyzer 28R 29 to U S Market at RNAi World Congress 4775 2febit to Introduce Geniom RT Analyzer 28R 29 to U S Market at RNAi World Congress 4775 3
Clearview C. Diff A is a one-step test for the direct qualitative detection of Clostridium difficile toxin A from fecal samples.
ThyroTest TSH is a rapid, qualitative test for hypothyroidism screening in adults.
...est is one of the easiest tests to run on the mark...s with no hands-on time. Critical care instruction...aving the pediatrician's office and valuable infor... to help control the spread of RSV infections. Now...
The BinaxNOW Influenza A & B Test simplifies rapid influenza testing. The easiest flu test on the market just got easier with accurate differentiation between influenza A and influenza B using one si
Medicine Products: